Media & Insight
Featured insights
Our news
-
Ambros Therapeutics Launches With $125 Million Series A
-
GSK Agrees to Acquire RAPT Therapeutics for $2.2 Billion
-
Parsons Acquires Altamira Technologies Corporation
-
Cooley Earns Top Industry-Leading Recognitions in US, Global M&A and Private Equity Rankings
-
Cooley Argues for Transgender Student Athletes Before US Supreme Court
Media coverage
-
Secondary Listings on SGX Set to Grow in 2026, but Regulatory Frictions Loom
-
Engagement Takes Centerstage as Systemic Shifts Hit Activism
-
Law360 Names Cooley Practice Group of the Year in Two Leading Areas
-
Litigator of the Week: Shout-Out
-
What Does 2026 Hold For Biopharma? Part 1: Capital Allocation And Dealmaking
Insights
-
FDA Opens Aperture for Wearables in Latest General Wellness Guidance
-
Automation Bias and Clinical Practice: FDA Makes Incremental Updates to Clinical Decision Support Software Guidance
-
FTC Issues 2026 HSR Filing Thresholds, Fee Adjustments and Interlocking Directorate Updates
-
Capital Markets Update – January 2026 One-Minute Reads
-
2025’s Defining AI Securities Litigation
Blogs
-
Disclosure: How the English Courts Balance Comity, Risk of Foreign Sanctions and the Fair Disposal of Proceedings
-
Vanguard’s Updated Voting Policies: Seven Things to Know
-
FTC Issues 2026 HSR Filing Thresholds, Fee Adjustments and Interlocking Directorate Updates
-
Tomorrow’s Webcast: “Proxy Disclosures – A Look at Potential Changes Ahead”
-
Shareholder Proposals: What Do the Exclusion Notices Look Like So Far?
Explore Cooley blogs
Related Contacts
Media contacts
